Next Article in Journal
Increased Reliance on Physician Assistants: An Access-Quality Tradeoff?
Previous Article in Journal
Does Supplementary Health Insurance Play a Role in the Switching Behaviour of Citizens in the Netherlands?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JMAHP
Volume 10
Issue 1
10.1080/20016689.2021.2022353
jmahp-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pricing Zolgensma—The World’s Most Expensive Drug

by
Mark Nuijten
Department Pricing and Valuation, A2M, Amsterdam, The Netherlands
J. Mark. Access Health Policy 2022, 10(1), 2022353; https://doi.org/10.1080/20016689.2021.2022353
Submission received: 9 August 2021 / Revised: 16 December 2021 / Accepted: 21 December 2021 / Published: 29 December 2022

Abstract

A heated discussion has recently broken out in Europe about the price of Zolgensma, ‘the most expensive drug ever’ [...]
Keywords: Price valuation reimbursement; orphan disease Price valuation reimbursement; orphan disease

Share and Cite

MDPI and ACS Style

Nuijten, M. Pricing Zolgensma—The World’s Most Expensive Drug. J. Mark. Access Health Policy 2022, 10, 2022353. https://doi.org/10.1080/20016689.2021.2022353

AMA Style

Nuijten M. Pricing Zolgensma—The World’s Most Expensive Drug. Journal of Market Access & Health Policy. 2022; 10(1):2022353. https://doi.org/10.1080/20016689.2021.2022353

Chicago/Turabian Style

Nuijten, Mark. 2022. "Pricing Zolgensma—The World’s Most Expensive Drug" Journal of Market Access & Health Policy 10, no. 1: 2022353. https://doi.org/10.1080/20016689.2021.2022353

APA Style

Nuijten, M. (2022). Pricing Zolgensma—The World’s Most Expensive Drug. Journal of Market Access & Health Policy, 10(1), 2022353. https://doi.org/10.1080/20016689.2021.2022353

Article Metrics

Back to TopTop